These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5081592)

  • 1. A quick reference chart on cross resistance between anticancer patients.
    Skipper HE; Hutchison DJ; Schabel FM; Schmidt LH; Goldin A; Brockman RW; Venditti JM; Wodinsky I
    Cancer Chemother Rep; 1972 Aug; 56(4):493-8. PubMed ID: 5081592
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of anticancer drugs.
    Cooney D; Kutzmits R
    Cancer Treat Rev; 1984 Dec; 11(4):269-74. PubMed ID: 6534508
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of prodigiozan and its combinations with cytostatic agents on experimental tumor growth].
    Ermol'eva AV; Givental' NI; Pasternak NA; Ravich IV
    Antibiotiki; 1966 Aug; 11(8):675-82. PubMed ID: 4970092
    [No Abstract]   [Full Text] [Related]  

  • 4. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
    Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanisms of the occurrence of tumor drug resistance and ways to overcome it].
    Belousova AK
    Vopr Onkol; 1978; 24(5):92-104. PubMed ID: 351956
    [No Abstract]   [Full Text] [Related]  

  • 6. [Theoretical and experimental bases for the polychemotherapy of cancer].
    Delobel J; Mawas C; Israel L
    Poumon Coeur; 1968; 24(1):5-8. PubMed ID: 5652207
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticancer chemotherapy and its place in the treatment of cancer].
    Coninx P; Lachapelle F; Pirenne Y
    Rev Med Liege; 1971 May; 26(10):351-4. PubMed ID: 5562609
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic synergism.
    Mantal N
    Cancer Chemother Rep 2; 1974 Mar; 4(1):147-9. PubMed ID: 4826493
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 10. [Membrane transport of anticancer drugs--potentiation of antitumor effect by calcium modifiers and overcoming of drug-resistance].
    Tsuruo T
    Tanpakushitsu Kakusan Koso; 1983 May; 28(6):865-71. PubMed ID: 6611960
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the selectivity of antitumor agents.
    Garattini S; Guaitani A; Nanni E; Palma V
    Cancer Res; 1967 Dec; 27(12 Pt 2):1309-437. PubMed ID: 4295303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resistance testing and chemotherapy results in animal and human tumors].
    Volm M; Mattern J; Wayss K
    Verh Dtsch Ges Pathol; 1978; 62():368. PubMed ID: 746886
    [No Abstract]   [Full Text] [Related]  

  • 13. An empirical cellular approach to the improvement of cancer chemotherapy.
    Bruce WR; Lin H
    Cancer Res; 1969 Dec; 29(12):2308-13. PubMed ID: 5369679
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of antineoplastic agents on strains of human breast carcinoma and chorioepithelioma transplanted into nude mice].
    Revazova ES
    Vestn Akad Med Nauk SSSR; 1981; (9):79-83. PubMed ID: 7197438
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
    Sigel MM; Lichter W; Lopez DM
    Cancer Chemother Rep 2; 1974 Mar; 4(1):109-14. PubMed ID: 4133186
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of olivomycin and bruneomycin and their combined use with prodigiozan on some nonspecific defense reactions of the host organism of transplanted lymphadenosis NK-LI].
    Shapovalova SP
    Antibiotiki; 1970 Oct; 15(10):924-8. PubMed ID: 4924376
    [No Abstract]   [Full Text] [Related]  

  • 17. Advantage of yeast polysaccharide-combined chemotherapy in mouse tumors.
    Kumano N; Nakai Y; Kurita K; Ishikawa T; Konno K
    Sci Rep Res Inst Tohoku Univ Med; 1978 Dec; 25(3-4):50-7. PubMed ID: 752924
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 19. Rationale for the use of alternating non-cross-resistant chemotherapy.
    Goldie JH; Coldman AJ; Gudauskas GA
    Cancer Treat Rep; 1982 Mar; 66(3):439-49. PubMed ID: 7060033
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the effectiveness of antitumor actions by the dynamics of tumor growth inhibition].
    Konradov AA; Karakulov RK
    Izv Akad Nauk SSSR Biol; 1986; (1):115-21. PubMed ID: 3950189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.